A sample text widget

Etiam pulvinar consectetur dolor sed malesuada. Ut convallis euismod dolor nec pretium. Nunc ut tristique massa.

Nam sodales mi vitae dolor ullamcorper et vulputate enim accumsan. Morbi orci magna, tincidunt vitae molestie nec, molestie at mi. Nulla nulla lorem, suscipit in posuere in, interdum non magna.

Roche and Biogen Suspend RA Treatment After Deaths

Swiss drugmaker Roche Holding AG and America’s Biogen Idec are suspending arthritis and lupus treatment Ocrelizumab after it caused deaths, marking the latest setback for Roche’s pipeline.

A safety monitoring board said it had seen serious and opportunistic infections in studies involving the drug and that some were fatal.

At the end of last year, Roche had said a late-stage trial of the experimental rheumatoid arthritis drug showed it significantly reduced the signs and symptoms of the painful joint disease.

Rheumatoid arthritis is an autoimmune disease characterized by inflammation that leads to stiff, swollen and painful joints. It affects some 20 million people, according to the National Rheumatoid Arthritis Society.

The drug is still being evaluated for relapsing multiple sclerosis and a Phase II study is on-going, Roche said.

VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>